Skip to content
2000
Volume 25, Issue 8
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Background

International guidelines recommend a pathway for preferable nursing handling in a specific cancer topic, like chemotherapy toxicity, low adhesion in toxicity reported with a consequential increase in adverse events (AEs) frequency, poorer QoL outcomes, and increased use of healthcare service until death. Unpredictability, postponed reports, and incapability to access healthcare services can compromise toxicity-related effects by including patients’ safety. In this scenario, a more attentive nursing intervention can improve patients’ outcomes and decrease costs for healthcare services, respectively. The present scoping review aims to describe and synthesize scientific care nursing evidence assessment in oncology patients.

Methods

PubMed, Embase, Nursing & Allied Health Database, and British Nursing were the databases examined. Keywords used and associated with Boolean operators were assessment, care, nursing, immune disorder, oncology, and patient. Research articles considered were published between 2013-2023. All systematic processes were performed according to the PRISMA procedure in order to reach all manuscripts considered in the present scoping review.

Results

The Embase database showed a total of 25 articles, PubMed displayed 77, the Nursing & Allied Health Database evidenced a total of 74, and the British Nursing database showed 252 records. Then, after a first revision in each database by considering the inclusion criteria, the abovementioned titles and abstracts were selected and, 336 records were removed, and 92 studies remained. Of these, 65 manuscripts were excluded after verifying abstracts. Finally, a total of 7 articles were carefully analysed and selected for this scoping review. Specifically, 2 articles belonged to the British Nursing Database, 3 articles belonged to Embase, 1 to the Nursing & Allied Health Database and one related to PubMed.

Conclusion

Oncology nursing should consider several aspects, such as therapy-related toxicity and its related morbidity and mortality, worsening levels of quality of life, and increasing duty by the healthcare organization or endorsements for the principal symptoms and signs which may anticipate few diseases and worst clinical conditions, too. Therefore, careful monitoring may allow prompt recognition and subsequent earlier management in the treatment efficacy.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/emiddt/10.2174/0118715303295330240719115132
2024-08-01
2025-10-14

  • From This Site

    /content/journals/emiddt/10.2174/0118715303295330240719115132
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MorganE. ArnoldM. CamargoM.C. GiniA. KunzmannA.T. MatsudaT. MeheusF. VerhoevenR.H.A. VignatJ. LaversanneM. FerlayJ. SoerjomataramI. The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study.E. Clinical. Medicine.2022474710140410.1016/j.eclinm.2022.10140435497064
     [Google Scholar]
  2. KennedyL.B. SalamaA.K.S. A review of cancer immunotherapy toxicity.CA Cancer J. Clin.20207028610410.3322/caac.2159631944278
     [Google Scholar]
  3. KroschinskyF. StölzelF. von BoninS. BeutelG. KochanekM. KiehlM. SchellongowskiP. New drugs, new toxicities: Severe side effects of modern targeted and immunotherapy of cancer and their management.Crit. Care20172118910.1186/s13054‑017‑1678‑128407743
     [Google Scholar]
  4. ZhangT. LiuY. YangL. Amplitude response and singularity behavior of circadian clock to external stimuli.NPJ Syst. Biol. Appl.2023913910.1038/s41540‑023‑00300‑w37573374
     [Google Scholar]
  5. KelleherF.C. RaoA. MaguireA. Circadian molecular clocks and cancer.Cancer Lett.2014342191810.1016/j.canlet.2013.09.04024099911
     [Google Scholar]
  6. FoxP. DarleyA. FurlongE. MiaskowskiC. PatirakiE. ArmesJ. ReamE. PapadopoulouC. McCannL. KearneyN. MaguireR. The assessment and management of chemotherapy-related toxicities in patients with breast cancer, colorectal cancer, and Hodgkin's and non-Hodgkin's lymphomas: A scoping review.Eur. J. Oncol. Nurs.201726638210.1016/j.ejon.2016.12.008
     [Google Scholar]
  7. GroverS. RahmaO.E. HashemiN. LimR.M. Gastrointestinal and hepatic toxicities of checkpoint inhibitors: Algorithms for management.Am. Soc. Clin. Oncol. Educ. Book.201838131910.1200/EDBK_100013
     [Google Scholar]
  8. MahendraratnamN. FarleyJ.F. BaschE. ProctorA. WheelerS.B. DusetzinaS.B. Characterizing and assessing antiemetic underuse in patients initiating highly emetogenic chemotherapy.Support. Care Cancer201927124525453410.1007/s00520‑019‑04730‑330915567
     [Google Scholar]
  9. DielensegerP. BörjesonS. VidallC. YoungA. JahnP. Evaluation of antiemetic practices for prevention of chemotherapy-induced nausea and vomiting (CINV): Results of a European oncology nurse survey.Support. Care Cancer201927114099410610.1007/s00520‑019‑04697‑130783815
     [Google Scholar]
  10. IJsbrandyC. OttevangerP.B. GerritsenW.R. van HartenW.H. HermensR.P.M.G. Determinants of adherence to physical cancer rehabilitation guidelines among cancer patients and cancer centers: A cross-sectional observational study.J. Cancer Surviv.202115116317710.1007/s11764‑020‑00921‑832986232
     [Google Scholar]
  11. ShengJ.Y. VisvanathanK. ThornerE. WolffA.C. Breast cancer survivorship care beyond local and systemic therapy.Breast201948Suppl. 1S103S10910.1016/S0960‑9776(19)31135‑X31839149
     [Google Scholar]
  12. TaiE. GuyG.P. DunbarA. RichardsonL.C. Cost of cancer-related neutropenia or fever hospitalizations, United States, 2012.J. Oncol. Pract.2017136e552e56110.1200/JOP.2016.01958828437150
     [Google Scholar]
  13. MaguireR. McCannL. KotronoulasG. KearneyN. ReamE. ArmesJ. PatirakiE. FurlongE. FoxP. GaigerA. McCroneP. BergG. MiaskowskiC. CardoneA. OrrD. FlowerdayA. KatsaragakisS. DarleyA. LubowitzkiS. HarrisJ. SkeneS. MillerM. MooreM. LewisL. DeSouzaN. DonnanP.T. Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART).BMJ2021374n164710.1136/bmj.n164734289996
     [Google Scholar]
  14. CurcioK. Instruments for assessing chemotherapy-induced peripheral neuropathy: A review of the literature.Clin. J. Oncol. Nurs.201620214415110.1188/16.CJON.20‑01AP26991707
     [Google Scholar]
  15. OakleyC. TaylorC. ReamE. MetcalfeA. Avoidant conversations about death by clinicians cause delays in reporting of neutropenic sepsis: Grounded theory study.Psychooncology201726101505151210.1002/pon.432027862571
     [Google Scholar]
  16. ChouinardA. CharpentierD. DoucetS. MessierC. VachonM.F. From theory to practice: Implementing a standardized, interactive education session on oral anticancer medication (OAM) for patients and their caregivers.Support. Care Cancer20202883897390410.1007/s00520‑019‑05236‑831848704
     [Google Scholar]
  17. NaZ. QiaoyuanY. BinghanW. QinZ. YueC. XinP. CuilianT. ChengY. A developed model of cancer patients participation in intravenous chemotherapy safety.Oncotarget2017850875988760610.18632/oncotarget.2098629152104
     [Google Scholar]
  18. BaschE. DealA.M. DueckA.C. ScherH.I. KrisM.G. HudisC. SchragD. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment.JAMA2017318219719810.1001/jama.2017.715628586821
     [Google Scholar]
  19. BaschE. PughS.L. DueckA.C. MitchellS.A. BerkL. FoghS. RogakL.J. GatewoodM. ReeveB.B. MendozaT.R. O’MaraA.M. DenicoffA.M. MinasianL.M. BennettA.V. SetserA. SchragD. RoofK. MooreJ.K. GergelT. StephansK. RimnerA. DeNittisA. BrunerD.W. Feasibility of patient reporting of symptomatic adverse events via the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in a chemoradiotherapy cooperative group multicenter clinical trial.Int. J. Radiat. Oncol. Biol. Phys.201798240941810.1016/j.ijrobp.2017.02.00228463161
     [Google Scholar]
  20. DürrP. SchlichtigK. KelzC. DeutschB. MaasR. EckartM.J. WilkeJ. WagnerH. WolffK. PreußC. BrücklV. MeidenbauerN. StaerkC. MayrA. FietkauR. GoebellP.J. KunathF. BeckmannM.W. MackensenA. NeurathM.F. PavelM. DörjeF. FrommM.F. The randomized AMBORA trial: Impact of pharmacological/pharmaceutical care on medication safety and patient-reported outcomes during treatment with new oral anticancer agents.J. Clin. Oncol.202139181983199410.1200/JCO.20.0308833822650
     [Google Scholar]
  21. MooneyK.H. BeckS.L. WongB. DunsonW. WujcikD. WhisenantM. DonaldsonG. Automated home monitoring and management of patient-reported symptoms during chemotherapy: Results of the symptom care at home RCT.Cancer Med.20176353754610.1002/cam4.100228135050
     [Google Scholar]
  22. AbsolomK. WarringtonL. HudsonE. HewisonJ. MorrisC. HolchP. CarterR. GibsonA. HolmesM. ClaytonB. RogersZ. McParlandL. ConnerM. GlidewellL. WoroncowB. DawkinsB. DickinsonS. HulmeC. BrownJ. VelikovaG. Phase III randomized controlled trial of eRAPID: eHealth intervention during chemotherapy.J. Clin. Oncol.202139773474710.1200/JCO.20.0201533417506
     [Google Scholar]
  23. LizéeT. BaschE. TrémolièresP. VoogE. DomontJ. PeyragaG. UrbanT. BennounaJ. SeptansA. L. BalavoineM. DetournayB. DenisF. Cost-effectiveness of web-based patient-reported outcome surveillance in patients with lung cancer.J Thorac Oncol20191461012102010.1016/j.jtho.2019.02.005
     [Google Scholar]
  24. OsbornJ. AjakaiyeA. CooksleyT. SubbeC. P. Do mHealth applications improve clinical outcomes of patients with cancer? A critical appraisal of the peer-reviewed literature.Support Care Cancer20202831469147910.1007/s00520‑019‑04945‑4
     [Google Scholar]
  25. MoradianS. VoelkerN. BrownC. LiuG. HowellD. Effectiveness of Internet-based interventions in managing chemotherapy-related symptoms in patients with cancer: A systematic literature review.Support Care Cancer201826236137410.1007/s00520‑017‑3900‑8
     [Google Scholar]
  26. Al MaqbaliM. Cancer-related fatigue: An overview.Br. J. Nurs.2021304S36S4310.12968/bjon.2021.30.4.S3633641391
     [Google Scholar]
  27. PedrettiL. MassaS. LeardiniD. MuratoreE. RahmanS. PessionA. EspositoS. MasettiR. Role of nutrition in pediatric patients with cancer.Nutrients202315371010.3390/nu1503071036771416
     [Google Scholar]
  28. NavariR.M. Managing nausea and vomiting in patients with cancer: What works.Oncology201832312113629548068
     [Google Scholar]
  29. de Melo GagliatoD. LeiX. GiordanoS.H. ValeroV. BarcenasC.H. HortobagyiG.N. Chavez-MacGregorM. Impact of delayed neoadjuvant systemic chemotherapy on overall survival among patients with breast cancer.Oncologist202025974975710.1634/theoncologist.2019‑074432431013
     [Google Scholar]
  30. HuL.Y. MiW.L. WuG.C. WangY.Q. Mao-YingQ.L. Prevention and treatment for chemotherapy-induced peripheral neuropathy: Therapies based on CIPN mechanisms.Curr. Neuropharmacol.201917218419610.2174/1570159X1566617091514321728925884
     [Google Scholar]
  31. BossiP. AntonuzzoA. ChernyN.I. RosengartenO. PernotS. TrippaF. SchulerU. SnegovoyA. JordanK. RipamontiC.I. Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines.Ann. Oncol.201829Suppl. 4iv126iv14210.1093/annonc/mdy14529931177
     [Google Scholar]
  32. DzierżanowskiT. MercadanteS. Constipation in cancer patients — an update of clinical evidence.Curr. Treat. Options Oncol.202223793695010.1007/s11864‑022‑00976‑y35441979
     [Google Scholar]
  33. Rivera-SalgadoD. Valverde-MuñozK. Ávila-AgüeroM. L. Chilean magazine of infectology.Rev. Chil. Infectol.20183511018201800010006210.4067/s0716‑10182018000100062
     [Google Scholar]
  34. TriaricoS. RinninellaE. CintoniM. CapozzaM.A. MastrangeloS. MeleM.C. RuggieroA. Impact of malnutrition on survival and infections among pediatric patients with cancer: A retrospective study.Eur. Rev. Med. Pharmacol. Sci.2019233116530779086
     [Google Scholar]
  35. FarrK.P. SafwatA. Palmar-plantar erythrodysesthesia associated with chemotherapy and its treatment.Case Rep. Oncol.20114122923510.1159/00032776721537373
     [Google Scholar]
  36. DengG. Integrative medicine therapies for pain management in cancer patients.Cancer J.201925534334810.1097/PPO.000000000000039931567462
     [Google Scholar]
  37. NuñezN.G. BernerF. FriebelE. UngerS. WyssN. GomezJ.M. PurdeM.T. NiedererR. PorschM. LichtensteigerC. KramerR. ErdmannM. SchmittC. HeinzerlingL. AbdouM.T. KarbachJ. SchadendorfD. ZimmerL. UgurelS. KlümperN. HölzelM. PowerL. KreutmairS. CaponeM. MadonnaG. CevhertasL. HeiderA. AmaralT. Hasan AliO. BomzeD. DimitriouF. DiemS. AsciertoP.A. DummerR. JägerE. DriessenC. LevesqueM.P. van de VeenW. JoergerM. FrühM. BecherB. FlatzL. Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors.Med (N. Y.)202342113129.e710.1016/j.medj.2022.12.00736693381
     [Google Scholar]
  38. ChennamadhavuniA. AbushahinL. JinN. PresleyC.J. ManneA. Risk factors and biomarkers for immune-related adverse events: A practical guide to identifying high-risk patients and rechallenging immune checkpoint inhibitors.Front. Immunol.20221377969110.3389/fimmu.2022.77969135558065
     [Google Scholar]
  39. LiW. KwokC.C.H. ChanD.C.W. HoA.W.Y. HoC.S. ZhangJ. WingY.K. WangF. TseL.A. Disruption of sleep, sleep-wake activity rhythm, and nocturnal melatonin production in breast cancer patients undergoing adjuvant chemotherapy: Prospective cohort study.Sleep Med.201955142110.1016/j.sleep.2018.11.02230743205
     [Google Scholar]
  40. ZhouL. ZhangZ. NiceE. HuangC. ZhangW. TangY. Circadian rhythms and cancers: The intrinsic links and therapeutic potentials.J. Hematol. Oncol.20221512110.1186/s13045‑022‑01238‑y35246220
     [Google Scholar]
  41. ChouF.Y. ChiuT.F. HuangF.W. HsuT.Y. LiuC.Y. LinC.H. HuangP.Y. LinK.M. WuS.H. The effect of exercise on the risk of metabolic syndrome associated with sleep insufficiency: A cross-sectional study.Front. Cardiovasc. Med.202310119224110.3389/fcvm.2023.119224137808885
     [Google Scholar]
  42. KrstevS. KnutssonA. Occupational risk factors for prostate cancer: A meta-analysis.J. Cancer Prev.20192429111110.15430/JCP.2019.24.2.9131360689
     [Google Scholar]
  43. MorganM.N. DvuchbabnyS. MartinezC.A. KerrB. CistulliP.A. CookK.M. The cancer clock is (not) ticking: Links between circadian rhythms and cancer.Clocks Sleep20191443545810.3390/clockssleep104003433089179
     [Google Scholar]
  44. BurchettJ.B. Knudsen-ClarkA.M. AltmanB.J. MYC ran up the clock: The complex interplay between myc and the molecular circadian clock in cancer.Int. J. Mol. Sci.20212214776110.3390/ijms2214776134299381
     [Google Scholar]
  45. MelnykB.M. Gallagher-FordL. LongL.E. Fineout-OverholtE. The establishment of evidence-based practice competencies for practicing registered nurses and advanced practice nurses in real-world clinical settings: Proficiencies to improve healthcare quality, reliability, patient outcomes, and costs.Worldviews Evid. Based Nurs.201411151510.1111/wvn.1202124447399
     [Google Scholar]
  46. PageM.J. McKenzieJ.E. BossuytP.M. BoutronI. HoffmannT.C. MulrowC.D. ShamseerL. TetzlaffJ.M. AklE.A. BrennanS.E. ChouR. GlanvilleJ. GrimshawJ.M. HróbjartssonA. LaluM.M. LiT. LoderE.W. Mayo-WilsonE. McDonaldS. McGuinnessL.A. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.BMJ202037271
     [Google Scholar]
  47. HeX. NgM. ChoiK. LiL. ZhaoW. ZhangM. SoW. Synergistic interactions among fatigue, sleep disturbance, and depression in women with breast cancer: A cross-sectional study.Oncol. Nurs. Forum202249324325410.1188/22.ONF.243‑25435446832
     [Google Scholar]
  48. ScheiberC. JohnstonL. PackerM. GevirtzR. EdwardsK. PaleshO. Heart rate variability markers as correlates of survival in recipients of hematopoietic cell transplantation.Oncol. Nurs. Forum201845225025910.1188/18.ONF.250‑25929466350
     [Google Scholar]
  49. GaillardV. LhuillierA. BigotC. PierardL. TrenszP. BurgyM. SchusterC. MaloufG. FritschA. LangH. TricardT. BorchielliniD. GeoffroisL. BarthelemyP. Impact of the app-based and nurse-led supportive care program AKO@dom on dose intensity of oral-targeted therapies in patients with metastatic renal cell cancer: A multicentric observational retrospective study.Support Care Cancer20223086583659110.1007/s00520‑022‑07088‑1
     [Google Scholar]
  50. Lai-KwonJ. KellyB. LaneS. BivianoR. BartulaI. BrennanF. KivikoskiI. ThompsonJ. DhillonH. M. MenziesA. LongG. V. Feasibility, acceptability, and utility of a nurse-led survivorship program for people with metastatic melanoma (MELCARE).Support Care Cancer202230119587959610.1007/s00520‑022‑07360‑4
     [Google Scholar]
  51. LuoX. CuiR. ZhangN. JiangH. ZhouL. WangX. Investigation and analysis of the comprehensive unmet needs of cancer patients treated with immune checkpoint inhibitors: A cross-sectional study.Support Care Cancer202331846010.1007/s00520‑023‑07911‑3
     [Google Scholar]
  52. MaC. L. ChangW. P. LinC. C. Rest/activity rhythm is related to the coexistence of pain and sleep disturbance among advanced cancer patients with pain.Support Care Cancer2014221879410.1007/s00520‑013‑1918‑0
     [Google Scholar]
  53. PurtzerM.A. Hermansen-KobulnickyC.J. ‘Being a Part of Treatment’: The meaning of self-monitoring for rural cancer patients.Cancer Nurs.20133629310310.1097/NCC.0b013e318263f38522964865
     [Google Scholar]
  54. HölblM. KomparaM. KamišalićA. Nemec ZlatolasL. A systematic review of the use of blockchain in healthcare.Symmetry2018101047010.3390/sym10100470
     [Google Scholar]
  55. HumphreysJ. JansonS. DoneskyD.A. DracupK. LeeK.A. PuntilloK. Theory of symptom management.Middle range theory for nursing. SmithM.J. LiehrP.R. ChamSpringer2014141164
     [Google Scholar]
  56. ZimmermannC. SwamiN. KrzyzanowskaM. HannonB. LeighlN. OzaA. MooreM. RydallA. RodinG. TannockI. DonnerA. LoC. Early palliative care for patients with advanced cancer: A cluster-randomised controlled trial.Lancet201438399301721173010.1016/S0140‑6736(13)62416‑224559581
     [Google Scholar]
  57. MustianK.M. ColeC.L. LinP.J. AsareM. FungC. JanelsinsM.C. KamenC.S. PepponeL.J. MagnusonA. Exercise recommendations for the management of symptoms clusters resulting from cancer and cancer treatments.Semin. Oncol. Nurs.201632438339310.1016/j.soncn.2016.09.00227776835
     [Google Scholar]
  58. KoelwynG.J. WennerbergE. DemariaS. JonesL.W. Exercise in regulation of inflammation-immune axis function in cancer initiation and progression.Oncology2015291290892226676894
     [Google Scholar]
  59. GentryM.T. AthertonP.J. LapidM. RosenP.S. KungS. RichardsonJ. NiaziS.K. BoboW.V. ClarkM.M. RummansT.A. Effects of a multidisciplinary quality of life intervention on sleep quality in patients with advanced cancer receiving radiation therapy.Palliat. Support. Care202018330731310.1017/S147895151900075031554519
     [Google Scholar]
  60. LarunL. BrurbergK.G. Odgaard-JensenJ. PriceJ.R. Exercise therapy for chronic fatigue syndrome.Cochrane Database Syst. Rev.20161212CD00320027995604
     [Google Scholar]
  61. LehrerP.M. GevirtzR. Heart rate variability biofeedback: How and why does it work?Front. Psychol.2014575610.3389/fpsyg.2014.0075625101026
     [Google Scholar]
  62. SternM.J. GuilesR.A.F. GevirtzR. HRV biofeedback for pediatric irritable bowel syndrome and functional abdominal pain: A clinical replication series.Appl. Psychophysiol. Biofeedback2014393-428729110.1007/s10484‑014‑9261‑x25274501
     [Google Scholar]
  63. SchakelL. VeldhuijzenD.S. CrompvoetsP.I. BoschJ.A. CohenS. van MiddendorpH. JoostenS.A. OttenhoffT.H.M. VisserL.G. EversA.W.M. Effectiveness of stress-reducing interventions on the response to challenges to the immune system: A Meta-Analytic review.Psychother. Psychosom.201988527428610.1159/00050164531387109
     [Google Scholar]
  64. WahbehH. HaywoodA. KaufmanK. HarlingN. ZwickeyH. Mind-body medicine and immune system outcomes: A systematic review.Open Complement. Med. J.200911253410.2174/1876391X0090101002523227136
     [Google Scholar]
  65. SephtonS. SpiegelD. Circadian disruption in cancer: A neuroendocrine-immune pathway from stress to disease?Brain Behav. Immun.200317532132810.1016/S0889‑1591(03)00078‑312946654
     [Google Scholar]
  66. WoodsD.W. PiacentiniJ.C. ScahillL. PetersonA.L. WilhelmS. ChangS. DeckersbachT. McGuireJ. SpechtM. ConeleaC.A. RozenmanM. DzuriaJ. LiuH. Levi-PearlS. WalkupJ.T. Behavior therapy for tics in children: Acute and long-term effects on psychiatric and psychosocial functioning.J. Child Neurol.201126785886510.1177/088307381039704621555779
     [Google Scholar]
  67. VgontzasA.N. ChrousosG.P. Sleep, the hypothalamic–pituitary–adrenal axis, and cytokines: Multiple interactions and disturbances in sleep disorders.Endocrinol. Metab. Clin. North Am.2002311153610.1016/S0889‑8529(01)00005‑612055986
     [Google Scholar]
  68. AlessiC.A. MartinJ.L. WebberA.P. Cynthia KimE. HarkerJ.O. JosephsonK.R. Randomized, controlled trial of a nonpharmacological intervention to improve abnormal sleep/wake patterns in nursing home residents.J. Am. Geriatr. Soc.200553580381010.1111/j.1532‑5415.2005.53251.x15877555
     [Google Scholar]
  69. KosterB.D. de GruijlT.D. van den EertweghA.J.M. Recent developments and future challenges in immune checkpoint inhibitory cancer treatment.Curr. Opin. Oncol.201527648248810.1097/CCO.000000000000022126352539
     [Google Scholar]
  70. WeberJ.S. YangJ.C. AtkinsM.B. DisisM.L. Toxicities of immunotherapy for the practitioner.J. Clin. Oncol.201533182092209910.1200/JCO.2014.60.037925918278
     [Google Scholar]
  71. SibaudV. Dermatologic reactions to immune checkpoint inhibitors.Am. J. Clin. Dermatol.201819334536110.1007/s40257‑017‑0336‑329256113
     [Google Scholar]
  72. LarkinJ. Chiarion-SileniV. GonzalezR. GrobJ.J. CoweyC.L. LaoC.D. SchadendorfD. DummerR. SmylieM. RutkowskiP. FerrucciP.F. HillA. WagstaffJ. CarlinoM.S. HaanenJ.B. MaioM. Marquez-RodasI. McArthurG.A. AsciertoP.A. LongG.V. CallahanM.K. PostowM.A. GrossmannK. SznolM. DrenoB. BastholtL. YangA. RollinL.M. HorakC. HodiF.S. WolchokJ.D. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma.N. Engl. J. Med.20153731233410.1056/NEJMoa150403026027431
     [Google Scholar]
  73. ZhouX. YaoZ. BaiH. DuanJ. WangZ. WangX. ZhangX. XuJ. FeiK. ZhangZ. TanF. XueQ. GaoS. GaoY. WangJ. HeJ. Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: A systematic review and meta-analysis.Lancet Oncol.20212291265127410.1016/S1470‑2045(21)00333‑834391508
     [Google Scholar]
  74. PuzanovI. DiabA. AbdallahK. BinghamC.O.III BrogdonC. DaduR. HamadL. KimS. LacoutureM.E. LeBoeufN.R. LenihanD. OnofreiC. ShannonV. SharmaR. SilkA.W. SkondraD. Suarez-AlmazorM.E. WangY. WileyK. KaufmanH.L. ErnstoffM.S. Managing toxicities associated with immune checkpoint inhibitors: Consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.J. Immunother. Cancer2017519510.1186/s40425‑017‑0300‑z29162153
     [Google Scholar]
  75. TaylorK. MonterossoL. BulsaraC. Qualitative results from a phase II pilot randomised controlled trial of a lymphoma nurse-led model of survivorship care.Eur. J. Oncol. Nurs.20183591410.1016/j.ejon.2018.01.011
     [Google Scholar]
  76. ThomB. BoekhoutA.H. CorcoranS. AdsuarR. OeffingerK.C. McCabeM.S. Advanced practice providers and survivorship care: They can deliver.J. Oncol. Pract.2019153e230e23710.1200/JOP.18.0035930615587
     [Google Scholar]
  77. SpearsJ. CraftM. WhiteS. Outcomes of Cancer survivorship care provided by advanced practice RNs compared to other models of care: A systematic review.Oncol. Nurs. Forum2017441E34E4110.1188/17.ONF.E34‑E4128067032
     [Google Scholar]
  78. ChanR.J. Crawford-WilliamsF. CrichtonM. JosephR. HartN.H. MilleyK. DruceP. ZhangJ. JeffordM. LisyK. EmeryJ. NekhlyudovL. Effectiveness and implementation of models of cancer survivorship care: An overview of systematic reviews.J. Cancer Surviv.202317119722110.1007/s11764‑021‑01128‑134786652
     [Google Scholar]
  79. MonterossoL. PlattV. BulsaraM. BergM. Systematic review and meta-analysis of patient reported outcomes for nurse-led models of survivorship care for adult cancer patients.Cancer Treat. Rev.201973627210.1016/j.ctrv.2018.12.00730639801
     [Google Scholar]
  80. LisyK. KentJ. DumbrellJ. KellyH. PiperA. JeffordM. Sharing cancer survivorship care between oncology and primary care providers: A qualitative study of health care professionals’ experiences.J. Clin. Med.202099299110.3390/jcm909299132947973
     [Google Scholar]
  81. FoxJ. JandaM. BennettF. LangbeckerD. An outreach telephone program for advanced melanoma supportive care: Acceptability and feasibility.Eur. J. Oncol. Nurs.20194211011510.1016/j.ejon.2019.08.010
     [Google Scholar]
  82. KoutsopoulouS. PapathanassoglouE.D.E. KatapodiM.C. PatirakiE.I. A critical review of the evidence for nurses as information providers to cancer patients.J. Clin. Nurs.2010195-674976510.1111/j.1365‑2702.2009.02954.x20500319
     [Google Scholar]
  83. BodenheimerT. WagnerE.H. GrumbachK. Improving primary care for patients with chronic illness.JAMA2002288141775177910.1001/jama.288.14.177512365965
     [Google Scholar]
  84. JerantA. MooreM. LorigK. FranksP. Perceived control moderated the self-efficacy-enhancing effects of a chronic illness self-management intervention.Chronic. Illn.20084317318210.1177/174239530808905718796506
     [Google Scholar]
/content/journals/emiddt/10.2174/0118715303295330240719115132
Loading
Care Nursing in Immune Disorder Assessment among Adult Oncology Patients: A Scoping Review
Endocr Metab Immune Disord Drug Targets 25, 618 (2025); https://doi.org/10.2174/0118715303295330240719115132
/content/journals/emiddt/10.2174/0118715303295330240719115132
/content/journals/emiddt/10.2174/0118715303295330240719115132
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article. Supplementary material, along with the published article, is available on the publisher’s website.

file format download Download

  • Article Type:     Review Article
Keyword(s): care; chemotherapy; chemotherapy toxicity; immune disorder; nursing; oncology; Oncology

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test